BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's Botanical Synthesis CDMO Services division has secured a new contract to develop a plant-based fragrance compound derived...
Biotechnology, Pharmaceuticals, Health
2025-05-21 8:30 AM EDT | BioHarvest Sciences Inc.
Safe Supply Streaming Co. Ltd. Announces Addition of Donovan Bailey and Jerry Dias to Board of Directors
Toronto, Ontario--(Newsfile Corp. - May 21, 2025) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company"), a leading investment company focused on advancing innovation in healthcare and harm reduction, is pleased to announce the appointment of Mr. Donovan Bailey and Mr. Jerry...
2025-05-21 8:25 AM EDT | Safe Supply Streaming Co Ltd.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import Permit.Following this major milestone approval, Red Light Holland will ship their carefully packaged raw psilocybin truffles...
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-05-21 8:18 AM EDT | Red Light Holland Corp.
NervGen Pharma to Present Topline Data for NVG-291 Phase 1b/2a Chronic Cohort Study at the American Spinal Injury Association Annual Scientific Meeting
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative therapeutics, today announced that topline results from the chronic cohort of the ongoing Phase 1b/2a study of NVG-291 will be presented as an oral presentation at...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-21 7:30 AM EDT | NervGen Pharma Corp.
Delivra Health and Its Brands Dream Water (TM) and Livrelief (TM) Report Positive Adjusted EBITDA(1) for Third Quarter of Fiscal 2025
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the three and nine months...
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-05-21 7:30 AM EDT | Delivra Health Brands Inc.
Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia
Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC-infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis...
Household/Consumer/Cosmetics, Sports, Cannabis, Health
2025-05-21 7:00 AM EDT | cbdMD
Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it exercised 3,200,000 common share purchase warrants (Warrants) of Satellos Bioscience Inc. (Corporation) at $0.50 per share for aggregate consideration of $1,600,000, and the remaining 3,360,474 unexercised Warrants expired. This resulted in...
Technology, Biotechnology, Investment Banking, Health
2025-05-20 7:01 PM EDT | Bloom Burton & Co. Inc.
FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
- Die Übereinstimmung mit den Vorgaben der FDA wurde bestätigt. Der Weg zu der wichtigen klinischen Studie in den USA ist somit frei -- 150-seitiger strategischer Geschäftsplan und genaue Finanzmodelle fertiggestellt -- Kontaktaufnahme mit Investoren zur Finanzierung der klinischen Durchführung und des Markteintritts im Gange -Vancouver, British Col
2025-05-20 3:48 PM EDT | Izotropic Corporation
Hemostemix Presents at TERMIS 2025, Freiburg, Germany
Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology company developing autologous stem cell therapies for cardiovascular diseases, is presenting its groundbreaking clinical trial results and regenerative medicine innovations today at the Tissue Engineering and Regenerative Medicine International Society...
Biotechnology, Pharmaceuticals, Health
2025-05-20 9:00 AM EDT | Hemostemix Inc.
Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform
Singapore, Singapore--(Newsfile Corp. - May 20, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today unveiled a new tele-dentistry service that is soon expected to let patients perform an AI-enhanced dental scan at home using the Company's MNDR telemedicine...
2025-05-20 8:30 AM EDT | Mobile-health Network Solutions
Promino Nutritional Sciences Inc. Comments on Trading Halt
Burlington, Ontario--(Newsfile Corp. - May 20, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") provides an update on the trading halt issued by the Canadian Investment Regulatory Organization and the cease trade order from the Ontario Securities Commission on Thursday,...
Food/Beverages, Sports, Health
2025-05-20 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference
Marlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-19 7:45 AM EDT | Phio Pharmaceuticals Corp.
medmix Named One of Only Nine Swiss Companies for Climate Leadership
Baar, Switzerland--(Newsfile Corp. - May 19, 2025) - medmix AG Neuhofstrasse 20CH-6430 Baarcommunications@medmix.comwww.medmix.swissMEDIA RELEASE DOWNLOAD MEDIA RELEASEmedmix named one
Technology, Healthcare and Hospitals, Household/Consumer/Cosmetics, Health
2025-05-19 6:19 AM EDT | medmix AG
Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to fund clinical execution and market entry -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - May 16, 2025) - Izotropic Corporation (CSE: IZO)...
2025-05-16 10:36 PM EDT | Izotropic Corporation
NervGen Pharma Grants Stock Options
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative therapeutics, today announced that it has granted 600,000 incentive stock options (the "Options") to directors and employees of the company. The Options are exercisable at a...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-16 4:30 PM EDT | NervGen Pharma Corp.
CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
This release corrects and replaces the press release issued by Adia Nutrition Inc., on May 16, 2025, at 8:09 am EDT.Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces its successful uplisting from the OTC...
Healthcare and Hospitals, Health
2025-05-16 10:11 AM EDT | Adia Nutrition Inc.
Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach
Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces that it has officially filed with OTC Markets Group for uplisting to the OTCQB Venture Market. This filing follows the successful completion of an independent...
Healthcare and Hospitals, Health
2025-05-16 8:09 AM EDT | Adia Nutrition Inc.
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is providing an update with respect to the management cease trade order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") on May 1,...
Technology, Pharmaceuticals, Health
2025-05-15 10:26 PM EDT | Beyond Medical Technologies Inc.
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical studyMarlborough, Massachusetts--(Newsfile Corp. - May 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-15 4:15 PM EDT | Phio Pharmaceuticals Corp.
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter
Charlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter...
Household/Consumer/Cosmetics, Sports, Cannabis, Health
2025-05-15 4:09 PM EDT | cbdMD